Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-25-004827
Filing Date
2025-11-14
Accepted
2025-11-14 08:15:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10316
  Complete submission text file 0001172661-25-004827.txt   12363
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Subject) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-60487 | Film No.: 251481388
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 2034090812
Deep Track Capital, LP (Filed by) CIK: 0001856083 (see all company filings)

EIN.: 853360885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A